Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
Wechter T, Cline A, Feldman SR. Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab. Ther Clin Risk Manag. 2018; 14:1489-1497.